Revealed: chemicals giant sold Louisiana plant amid fears over cost of offsetting toxic emissions
Multibillion-dollar company DuPont worried about the potential cost of offsetting emissions of a ‘likely human carcinogen’
Chemicals giant DuPont decided to sell a plant in south Louisiana that emits a likely cancer causing pollutant, citing “major concerns” that government agencies would regulate its emissions to protect the community living nearby, internal documents seen by the Guardian reveal.
The documents show the multibillion-dollar company worried in 2011 about the potential cost of offsetting its emissions of the “likely human carcinogen”, chloroprene, and so moved to sell the plant, the Pontchartrain Works facility.